Biotech trend — Disruption score: 8.6/10
A laboratory-evolved CRISPR-associated transposase achieving 200-fold increased activity in human cells represents a genuine breakthrough in programmable gene insertion, potentially enabling single universal treatments for entire classes of genetic diseases rather than mutation-specific therapies.
Paradigm Shift detected
Loading…